5-Chloro-3-methylpyrazin-2-amine

Catalog No.: 
ACXEVT816
CAS No.: 
1001050-30-1
Molecular Formula: 
C5H6ClN3
Molecular Weight: 
143.58
5-Chloro-3-methylpyrazin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$94.00InquiryInquiry
250mg95%$174.00InquiryInquiry
1g95%$414.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-3-methylpyrazin-2-amine
IUPAC Name5-chloro-3-methylpyrazin-2-amine
MDL No.MFCD09881411
Molecular FormulaC5H6ClN3
Molecular Weight143.58
SMILESNC1=NC=C(Cl)N=C1C
InChI KeyJQIRKTCPIIGFIK-UHFFFAOYSA-N
Synonym5-Chloro-3-methylpyrazin-2-amine | 1001050-30-1 | 2-Pyrazinamine, 5-chloro-3-methyl- | SCHEMBL14938822 | SCHEMBL21301248 | DTXSID60698467 | JQIRKTCPIIGFIK-UHFFFAOYSA-N | 5-Chloro-3-methylpyrazin-2-ylamine | MFCD09881411 | AKOS006312380 | AB54525 | AS-50667 | CS-0050521 | EN300-194
CAS No.1001050-30-1
PubChem CID53424289

Synthetic Route by SureRoute

1. ACXEVT816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFQEN946 route compound structure diagram
    ACFQEN94619838-08-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXEVT816 route product structure diagram
    ACXEVT8161001050-30-1
Inquiry

2. ACXEVT816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFQEN946 route compound structure diagram
    ACFQEN94619838-08-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXEVT816 route product structure diagram
    ACXEVT8161001050-30-1
Inquiry

3. ACXEVT816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEVT816 route product structure diagram
    ACXEVT8161001050-30-1
Inquiry

Comments (0)